Becton Dickinson

Becton Dickinson, commonly known as BD, is a global leader in medical technology that advances the world of health by improving medical discovery, diagnostics, and the delivery of care. Founded in 1897, BD has a rich history of innovation and commitment to enhancing patient outcomes through its diverse range of products and services.

The company operates in three primary segments: BD Medical, BD Diagnostics, and BD Biosciences. Each segment focuses on different aspects of healthcare, from developing medical devices and instruments to providing diagnostic solutions and research tools.

• BD Medical: This segment specializes in the development of medical devices that are essential for safe and effective patient care, including syringes, needles, and infusion systems.
• BD Diagnostics: BD Diagnostics offers a wide array of diagnostic systems and reagents that help healthcare professionals detect diseases and manage patient health more effectively.
• BD Biosciences: This division provides innovative tools for researchers in life sciences, enabling advancements in cellular analysis and drug discovery.

BD is committed to sustainability and corporate responsibility, striving to make a positive impact on communities and the environment. The company invests heavily in research and development to ensure it remains at the forefront of medical technology, continuously seeking to improve its products and services.

With a presence in over 190 countries, Becton Dickinson is dedicated to enhancing the quality of healthcare worldwide. The company’s vision is to empower healthcare professionals and patients alike, ensuring that they have access to the best possible medical solutions.